China Universal Asset Management »

Abcellera Biologics shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $147k 57k 2.60
2024-06-30 $102k 35k 2.96
2024-03-31 $255k 56k 4.53
2023-12-31 $192k 34k 5.71
2023-09-30 $34k 7.4k 4.60
2023-06-30 $25k 3.8k 6.46
2023-03-31 $29k 3.9k 7.54
2022-12-31 $29k 2.9k 10.13
2022-09-30 $26k 2.7k 9.74

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Broadcom Common Stock (AVGO)
Vertex Pharmaceuticals Common Stock (VRTX)
Alphabet Inc-cl A Common Stock (GOOGL)
Gilead Sciences Common Stock (GILD)
Amgen Common Stock (AMGN)
Regeneron Pharmaceuticals Common Stock (REGN)
Taiwan Semiconductor-sp Adr (TSM)
Netflix Common Stock (NFLX)
Servicenow Common Stock (NOW)
Visa Inc-class A Shares Common Stock (V)

View all positions for China Universal Asset Management

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Baillie Gifford & Co
Ing Investment Management
OrbiMed Advisors
Arrowpoint Asset Management
BlackRock
BlackRock
Renaissance Technologies
Tang Capital Management
Federated Investors
Two Sigma Investments
Guardian Capital Advisors
Two Sigma Advisers
Citadel Advisors
Novo A/S

View all funds holding Abcellera Biologics